Trial description:
Randomised, phase II/III, 3 stage trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in breast cancer patients with TNBC and/or gBRCA
Contact name:
Dr Jean Abraham
Trial start date:
Thursday, May 12, 2016
Trial end date:
Wednesday, March 31, 2021
Trial tumour type:
Breast
Show on Radiotherapy:
No
